Latest Asx News

Osteopore Limited has completed the full subscription of Tranche 1 under its A$20 million convertible notes facility, raising an additional A$250,000 to support ongoing business and future projects.

MetalsTech Limited is progressing its Pre-Feasibility Study for the Sturec Gold Mine in Slovakia, targeting completion in the first half of 2026, alongside key board appointments aimed at driving the project forward.

BlackRock Investment Management (Australia) Limited has announced the Distribution Reinvestment Plan (DRP) prices for several Australian-domiciled iShares ETFs for the December 2025 distribution period, providing key details for investors opting into reinvestment.

Metgasco shareholders have approved the sale of their 25% stake in the Southern Flank joint ventures to Vintage Energy, marking a key milestone in Vintage’s strategic expansion. The deal still awaits final conditions before completion.

Tasman Resources has clarified the reasons behind its recent share price jump, pointing to a significant new investor, upcoming drilling programs, and a rising stake in Eden Innovations. The company reassures the market it remains fully compliant with ASX disclosure rules.

Eagle Mountain Mining has closed its entitlement offer, raising just over half of its targeted $1.98 million, with a significant shortfall to be placed alongside lead managers. The funds will support its copper-gold exploration projects in Arizona.

3D Energi has confirmed a new gas discovery at the Charlemont-1 well in Victoria’s Otway Basin, reinforcing the prospectivity of the Charlemont Trend and the potential for increased domestic gas supply.

Recce Pharmaceuticals has received a $5.3 million R&D tax rebate from the Australian Taxation Office, providing a significant cash injection to support its innovative synthetic anti-infective drug development programs.

Atomic Eagle Limited has completed a 69-hole drilling program at its Chisebuka target in Zambia, revealing extensive shallow uranium mineralisation and setting the stage for a major resource upgrade across the Muntanga Project.

Neuren Pharmaceuticals’ partner Acadia projects DAYBUE sales to reach around US$700 million by 2028, driven by US market expansion and international approvals. The launch of a new formulation and ongoing clinical trials in Japan underpin this optimistic outlook.

Ballymore Resources has reported its richest drill intersection yet at the Torpy’s prospect near Chillagoe, Queensland, revealing exceptionally high-grade silver, lead, zinc, and indium mineralisation. This breakthrough highlights the growing potential of the Torpy’s area and sets the stage for further exploration in 2026.

betr Entertainment has reported a robust 24.5% increase in turnover for Q2 FY26 alongside a strategic on-market share buy-back of up to 10%, signalling confidence in its intrinsic value and growth prospects.